These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32620060)

  • 1. Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease.
    Júlio F; Ribeiro MJ; Morgadinho A; Sousa M; van Asselen M; Simões MR; Castelo-Branco M; Januário C
    Disabil Rehabil; 2022 Mar; 44(6):921-939. PubMed ID: 32620060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Ecological Approach Reveals Early Executive Function Impairments in Huntington's Disease.
    Júlio F; Ribeiro MJ; Patrício M; Malhão A; Pedrosa F; Gonçalves H; Simões M; van Asselen M; Simões MR; Castelo-Branco M; Januário C
    Front Psychol; 2019; 10():585. PubMed ID: 30967810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Self-awareness of deficits in Huntington's and Parkinson's disease].
    Sitek EJ; Sławek J; Wieczorek D
    Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of age on everyday cognitive function with a virtual environment task: The
    Júlio F; Ribeiro MJ; Simões MR; Castelo-Branco M; Januário C
    Appl Neuropsychol Adult; 2023 Oct; ():1-11. PubMed ID: 37847996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-awareness of executive dysfunction in Huntington's disease: comparison with Parkinson's disease and cervical dystonia.
    Sitek EJ; Sołtan W; Wieczorek D; Schinwelski M; Robowski P; Harciarek M; Guzińska K; Sławek J
    Psychiatry Clin Neurosci; 2013 Jan; 67(1):59-62. PubMed ID: 23331288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spoken language production in Huntington's and Parkinson's diseases.
    Murray LL
    J Speech Lang Hear Res; 2000 Dec; 43(6):1350-66. PubMed ID: 11193957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson's and Huntington's diseases.
    Carelli L; Solca F; Migliore S; Torre S; Brugnera A; Mancini F; Tagini S; Ferrucci R; Maffi S; Ceccarelli C; Pasquini J; Sassone J; Squitieri F; Ciammola A; Silani V; Poletti B
    Neurol Sci; 2021 Dec; 42(12):4997-5006. PubMed ID: 33728549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
    Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
    J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
    Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
    Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.
    Aiello EN; Solca F; Torre S; Lafronza A; Maranzano A; Bonetti R; Scheveger F; Maffi S; Ceccarelli C; Scocchia M; Casella M; Verde F; Migliore S; Silani V; Ticozzi N; Squitieri F; Ciammola A; Poletti B
    Neurol Sci; 2024 Mar; 45(3):1079-1086. PubMed ID: 37770762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.
    Aldaz T; Nigro P; Sánchez-Gómez A; Painous C; Planellas L; Santacruz P; Cámara A; Compta Y; Valldeoriola F; Martí MJ; Muñoz E
    J Neurol; 2019 Jun; 266(6):1340-1350. PubMed ID: 30834978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases.
    Sprengelmeyer R; Canavan AG; Lange HW; Hömberg V
    Mov Disord; 1995 Jan; 10(1):51-65. PubMed ID: 7885356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor learning by imagery is differentially affected in Parkinson's and Huntington's diseases.
    Yágüez L; Canavan AG; Lange HW; Hömberg V
    Behav Brain Res; 1999 Jul; 102(1-2):115-27. PubMed ID: 10403020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
    Martinez-Horta S; Horta-Barba A; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Garcia-Ruiz P; Júlio F; Januário C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Neurol; 2020 May; 267(5):1527-1535. PubMed ID: 32030521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productive syntax abilities in Huntington's and Parkinson's diseases.
    Murray LL; Lenz LP
    Brain Cogn; 2001; 46(1-2):213-9. PubMed ID: 11527333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a performance-rating method to assess awareness of cognitive functioning in Huntington's disease.
    Hergert DC; Haaland KY; Cimino CR
    Clin Neuropsychol; 2020 Apr; 34(3):477-497. PubMed ID: 31322031
    [No Abstract]   [Full Text] [Related]  

  • 20. Measuring the functional impact of cognitive impairment in Huntington's disease.
    Horta-Barba A; Martínez-Horta S; Pérez-Pérez J; Sampedro F; Puig-Davi A; Pagonabarraga J; Kulisevsky J
    J Neurol; 2022 Jul; 269(7):3541-3549. PubMed ID: 35061089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.